Anti-Müllerian hormone versus antral follicle count as first-choice biomarkers in a low-resource setting: A cross-sectional study in Kumasi, Ghana

Francis Jojo Moses Kwadzo Damalie, Kweku Bedu-Addo, Charles Mawunyo Senaya, Edward Tieru Dassah, Alexander Anning, Phillip Kweku Baidoo, Kofi Owusu-Daaku, Patrick Addo-Fordjour · 2026

Read Anti-Müllerian hormone versus antral follicle count as first-choice biomarkers in a low-resource setting: A cross-sectional study in Kumasi, Ghana by Francis Jojo Moses Kwadzo Damalie, Kweku Bedu-Addo, Charles Mawunyo Senaya, Edward Tieru Dassah, Alexander Anning, Phillip Kweku Baidoo, Kofi Owusu-Daaku, Patrick Addo-Fordjour (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13291566.txt.

Description

Two egg reserve tests disagree in women seeking fertility care in Ghana. Francis Jojo Moses Kwadzo Damalie leads a 2026 study in Kumasi. Clinics must pick a first test in low-resource settings. Blood hormone AMH and follicle counts are the two options.

The study held 372 women at a private fertility hospital. Both tests were charted by age group. Each test fell with age in a curved pattern. Both peaked in the mid twenties. Follicle counts flagged low reserve two years earlier. They also caught more low-reserve cases overall. The two tests agreed poorly on single women. Local cost and skill should guide the first pick.

Catalog record

CREATORFrancis Jojo Moses Kwadzo Damalie, Kweku Bedu-Addo, Charles Mawunyo Senaya, Edward Tieru Dassah, Alexander Anning, Phillip Kweku Baidoo, Kofi Owusu-Daaku, Patrick Addo-Fordjour
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30390
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13291566

Browse the full library · About the Tower of Babel